Last reviewed · How we verify

NCT02354248

Application of the Triple Stimulation Technique to Patients With CNS Disorders Including Stroke

Completed NA Last updated 23 January 2018
What this trial tests

NA trial testing Triple stimulation technique in Stroke Patients in 100 participants. Completed in 13 September 2016.

Timeline
11 June 2014
Primary endpoint
13 September 2016
13 September 2016

Quick facts

Lead sponsorBrugmann University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment100
Start date11 June 2014
Primary completion13 September 2016
Estimated completion13 September 2016
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Brugmann University Hospital

Who can join

18 and older, any sex, with Stroke Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

TST (Triple stimulation technique) helps to better quantify the proportion of motor units activated by transcranial magnetic stimulation. The abnormal amplitude registered by TST is proportional to the intensity of conduction disorders. The evaluation of these disorders is more precise with this technique than with the slowing of the central conduction time (CCT). The investigators propose to use this technique in CNS pathologies where this disorder is significant and essential, like multiple sclerosis and stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke Patients

Currently open trials in the same condition.

Other Brugmann University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02354248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing